Friday, April 17, is “End Alz Day”, a day of unity in the fight against Alzheimer’s. “On this day, we stand together to raise ...

LUBBOCK, Texas—Grab a racket for Do What You Love to End Alzheimer’s. Lubbock Indoor Pickleball is doing what they LOVE to ...

Alzheon, Inc., a clinical-stage biopharmaceutical company developing a broad portfolio of investigational therapies and ...

STRONG WILL BE PARTICIPATING IN THE RIDE TO END ALZHEIMER’S IN SOUTH CAROLINA CYCLING MORE THAN 200 MILES TO RAISE MONEY AND AWARENESS FOR ALZHEIMER’S. IN MAY OF 2021. WYFF NEWS FORCE GEOFF HART ...

FRAMINGHAM, Mass.--(BUSINESS WIRE)--Alzheon, Inc., a clinical-stage biopharmaceutical company focused on developing new medicines for patients suffering from Alzheimer’s disease (AD) and other ...

Please provide your email address to receive an email when new articles are posted on . Alzheon Inc. has enrolled patients who completed either phase 2 or phase 3 trials to evaluate ALZ-801 as a ...

NEW YORK, April 2, 2025 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a biopharmaceutical company focused on developing innovative treatments for unmet medical needs, today announced ...

ALZ-NET is the first network developed specifically for new FDA-approved Alzheimer's treatments, collecting real-world evidence on drug effectiveness and side effects over a long period of time. The ...

The collaboration targets increased awareness of amyloid-related imaging abnormalities monitoring.

As amyloid immunotherapy enters clinical care in more countries, providers the world over are eager for more information on how well it works, and especially how safe it is. To collect such data in ...

NEWBERRY, S.C. (WCSC) - The July heat isn’t stopping hundreds of cyclists from pedaling from one side of South Carolina to the other over the next three days. Their goal is to support those fighting ...